Director buying at Nova Leap Health (NLH)

Director buying at Nova Leap Health (V:NLH)

Christopher Donald Dobbin, a Director, acquired 500,000 Common Shares on an indirect ownership basis for registered holder Precipice Holdings Limited at a price of $0.250 through a private transaction on February 23rd, 2018. The insider also acquired 250,000 Warrants with an exercise price of $0.375 until February 22nd, 2020. This represents a $125,000 investment into the company's shares and an account share holdings change of 17.1%.

Nova Leap is focused on a highly fragmented market of small privately-held companies providing patients one on one care in their homes. Nova Leap's post acquisition organic growth strategy is to increase annual revenue per location through a combination of increased employee investment, including training, focused sales and marketing efforts, billing rate increases, expansion of geographical coverage, and improved referral sources.